SCHEMBL22188458

SCHEMBL22188458

Cc1oncc1C(O)C(N)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
BLM P54132 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
NR1I2 O75469 1/20 0.39
PTGS1 P23219 1/20 0.39
ADRA1A P35348 1/20 0.39
ACHE P22303 1/20 0.39
CSF1R P07333 1/20 0.34
GRIA1 P42261 1/20 0.33
GRIA3 P42263 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC7A5 Q01650 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
CYP1A2 P05177 2/20 0.32
GMNN O75496 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20501825 0.75 CSF1R (0.37) LMNABLMPTGS1CSF1RALDH1A1
SCHEMBL6422740 0.67 GRIA1 (0.49) LMNABLMTDP1PTGS1GRIA1
SCHEMBL21853771 0.66 LMNA (0.58) LMNABLMTDP1NR1I2PTGS1
SCHEMBL21853772 0.66 LMNA (0.58) LMNABLMTDP1NR1I2PTGS1
SCHEMBL2759117 0.65
SCHEMBL13957618 0.65 LMNA (0.43) LMNABLMTDP1NR1I2PTGS1
SCHEMBL9320152 0.64 ACHE (0.58) LMNABLMPTGS1ADRA1AACHE
SCHEMBL3101768 0.64 PTPRA (0.37) LMNABLMCSF1RGRIA1GRIA3
SCHEMBL21853765 0.63 SLC1A2 (0.45) LMNABLMTDP1NR1I2PTGS1
SCHEMBL21853764 0.63 SLC1A2 (0.45) LMNABLMTDP1NR1I2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240141291-A1 FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES 2024-05-02 US disclosed
WO-2024044355-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROGENERATIVE DISEASE 1/1THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2024-02-29 WO disclosed
US-20200215147-A1 METHODS FOR TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER CARMEL HAIFA UNIVERSITY ECONOMIC CORPORATION LTD. (IL) 2020-07-09 US disclosed